Live stream preview
LDN Compounding Opportunities: Post-COVID, Autoimmune, Dermatology, and More
2h 15m
Run time: 2 hour 15 minutes
Download handout: https://bit.ly/3P7ZGhY
This compilation of four presentations from PCCA’s Clinical Compounding Pharmacists will feature presentations covering formulas to help with symptoms related to Parkinson’s Disease, Multiple Sclerosis, ALS, Hashimoto’s and Lupus. Topics related to long term complications associated with COVID-19 and the role of LDN will be addressed as well as new literature on the use of naltrexone in various conditions. Content on topical versus transdermal delivery of naltrexone and dermatological conditions will also be discussed.